Related Experiment Video
Updated: Mar 19, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome
Irina V Prokhorova1, Kseniya A Akulich2,3, Desislava S Makeeva2,3
1Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM U964, CNRS UMR7104, Université de Strasbourg, 67404, Illkirch, France.
Abstract:
Amicoumacin A is an antibiotic that was recently shown to target bacterial ribosomes. It affects translocation and provides an additional contact interface between the ribosomal RNA and mRNA. The binding site of amicoumacin A is formed by universally conserved nucleotides of rRNA. In this work, we showed that amicoumacin A inhibits translation in yeast and mammalian systems by affecting translation elongation. We determined the structure of the amicoumacin A complex with yeast ribosomes at a resolution of 3.1 Å. Toxicity measurement demonstrated that human cancer cell lines are more susceptible to the inhibition by this compound as compared to non-cancerous ones. This might be used as a starting point to develop amicoumacin A derivatives with clinical value.
Insights
Amicoumacin A antibiotic inhibits translation by targeting bacterial ribosomes, affecting elongation in yeast and mammalian systems. Cancer cells show higher susceptibility, suggesting potential for new drug development.
Area of Science:
- Molecular Biology
- Biochemistry
- Antimicrobial Research
Background:
- Amicoumacin A is an antibiotic targeting bacterial ribosomes.
- It influences translocation and creates an additional binding interface between ribosomal RNA and messenger RNA.
- The drug's binding site involves universally conserved ribosomal RNA nucleotides.
Purpose of the Study:
- To investigate amicoumacin A's inhibitory effects on translation in yeast and mammalian systems.
- To determine the structural basis of amicoumacin A binding to ribosomes.
- To assess the differential toxicity of amicoumacin A towards cancerous versus non-cancerous cells.
Main Methods:
- Inhibition assays in yeast and mammalian translation systems.
- Cryo-electron microscopy to determine the structure of the amicoumacin A-yeast ribosome complex.
- Toxicity measurements using human cancer and non-cancerous cell lines.
Main Results:
- Amicoumacin A was shown to inhibit translation elongation in both yeast and mammalian systems.
- The structure of amicoumacin A complexed with yeast ribosomes was determined at 3.1 Å resolution.
- Human cancer cell lines exhibited greater susceptibility to amicoumacin A inhibition compared to non-cancerous cells.
Conclusions:
- Amicoumacin A effectively inhibits translation elongation in eukaryotic systems.
- The structural data provides insights into the mechanism of action.
- The differential toxicity suggests potential for developing targeted cancer therapies.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Inhibitors of Bacterial Protein Synthesis
Experimental RNAi
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

